You have to be kidding! Most of the vaccine development projects are partnerships. Inovio is collaborating with biopharma that own purified or recombinant antigens that are used to make the vaccine. Inovio will obviously partner with more companies in the future to make new vaccines based upon their patented electroporation and antigen preparation methods. I am answering your post just before I put you on "ignore."